Show Summary Details
Page of

Pharmacological Management of Insomnia 

Pharmacological Management of Insomnia
Chapter:
Pharmacological Management of Insomnia
Author(s):

Karl Doghramji

DOI:
10.1093/med/9780190929671.003.0009
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 04 August 2021

Insomnia has posed a management challenge for patients and clinicians for centuries. Historically, a variety of compounds have been utilized for the treatment of this common malady, with many of them associated with unwanted side effects. Over the past few decades, however, a variety of agents have emerged for treatment of insomnia with improved safety profiles. This chapter reviews these agents, with attention to their pharmacokinetic profile, mechanism of action, and other, clinically relevant characteristics. It also discusses a rational approach in the selection of each agent to optimize the treatment of insomnia. The chapter closes with a look toward the future of the pharmacological management of insomnia.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.